Biallelic pathogenic variants of PARS2 cause developmental and epileptic encephalopathy with spike-and-wave activation in sleep.
PARS2
continuous spikes and waves during slow sleep (CSWS)
developmental and epileptic encephalopathy (DEE)
spike-and-wave activation in sleep (SWAS)
Journal
Molecular genetics & genomic medicine
ISSN: 2324-9269
Titre abrégé: Mol Genet Genomic Med
Pays: United States
ID NLM: 101603758
Informations de publication
Date de publication:
13 Dec 2023
13 Dec 2023
Historique:
revised:
06
10
2023
received:
31
07
2023
accepted:
13
10
2023
medline:
13
12
2023
pubmed:
13
12
2023
entrez:
13
12
2023
Statut:
aheadofprint
Résumé
Biallelic pathogenic variants in the mitochondrial prolyl-tRNA synthetase 2 gene (PARS2, OMIM * 612036) have been associated with Developmental and Epileptic Encephalopathy-75 (DEE-75, MIM #618437). This condition is typically characterized by early-onset refractory infantile spasms with hypsarrhythmia, intellectual disability, microcephaly, cerebral atrophy with hypomyelination, lactic acidemia, and cardiomyopathy. Most affected individuals do not survive beyond the age of 10 years. We describe a patient with early-onset DEE, consistently showing an EEG pattern of Spike-and-Wave Activation in Sleep (SWAS) since childhood. The patient underwent extensive clinical, metabolic and genetic investigations, including whole exome sequencing (WES). WES analysis identified compound heterozygous variants in PARS2 that have been already reported as pathogenic. A literature review of PARS2-associated DEE, focusing mainly on the electroclinical phenotype, did not reveal the association of SWAS with pathogenic variants in PARS2. Notably, unlike previously reported cases with the same genotype, this patient had longer survival without cardiac involvement or lactic acidosis, suggesting potential genetic modifiers contributing to disease variability. These findings widen the genetic heterogeneity of DEE-SWAS, including PARS2 as a causative gene in this syndromic entity, and highlight the importance of prolonged sleep EEG recording for the recognition of SWAS as a possible electroclinical evolution of PARS2-related DEE.
Sections du résumé
BACKGROUND
BACKGROUND
Biallelic pathogenic variants in the mitochondrial prolyl-tRNA synthetase 2 gene (PARS2, OMIM * 612036) have been associated with Developmental and Epileptic Encephalopathy-75 (DEE-75, MIM #618437). This condition is typically characterized by early-onset refractory infantile spasms with hypsarrhythmia, intellectual disability, microcephaly, cerebral atrophy with hypomyelination, lactic acidemia, and cardiomyopathy. Most affected individuals do not survive beyond the age of 10 years.
METHODS
METHODS
We describe a patient with early-onset DEE, consistently showing an EEG pattern of Spike-and-Wave Activation in Sleep (SWAS) since childhood. The patient underwent extensive clinical, metabolic and genetic investigations, including whole exome sequencing (WES).
RESULTS
RESULTS
WES analysis identified compound heterozygous variants in PARS2 that have been already reported as pathogenic. A literature review of PARS2-associated DEE, focusing mainly on the electroclinical phenotype, did not reveal the association of SWAS with pathogenic variants in PARS2. Notably, unlike previously reported cases with the same genotype, this patient had longer survival without cardiac involvement or lactic acidosis, suggesting potential genetic modifiers contributing to disease variability.
CONCLUSION
CONCLUSIONS
These findings widen the genetic heterogeneity of DEE-SWAS, including PARS2 as a causative gene in this syndromic entity, and highlight the importance of prolonged sleep EEG recording for the recognition of SWAS as a possible electroclinical evolution of PARS2-related DEE.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2311Informations de copyright
© 2023 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.
Références
Al Balushi, A., Matviychuk, D., Jobling, R., Salomons, G. S., Blaser, S., & Mercimek-Andrews, S. (2020). Phenotypes and genotypes of mitochondrial aminoacyl-tRNA synthetase deficiencies from a single neurometabolic clinic. JIMD Reports, 51(1), 3-10. https://doi.org/10.1002/jmd2.12079
Almuqbil, M., Vernon, H. J., Ferguson, M., & Kline, A. D. (2020). PARS2-associated mitochondrial disease: A case report of a patient with prolonged survival and literature review. Molecular Genetics and Metabolism Reports, 24, 100613. https://doi.org/10.1016/j.ymgmr.2020.100613
Caraballo, R. H., Veggiotti, P., Kaltenmeier, M. C., Piazza, E., Gamboni, B., Avaria, M. F. L., Noli, D., Adi, J., & Cersosimo, R. (2013). Encephalopathy with status epilepticus during sleep or continuous spikes and waves during slow sleep syndrome: A multicenter, long-term follow-up study of 117 patients. Epilepsy Research, 105(1-2), 164-173. https://doi.org/10.1016/j.eplepsyres.2013.02.010
Carvill, G. L., Regan, B. M., Yendle, S. C., O'Roak, B. J., Lozovaya, N., Bruneau, N., Burnashev, N., Khan, A., Cook, J., Geraghty, E., Sadleir, L. G., Turner, S. J., Tsai, M. H., Webster, R., Ouvrier, R., Damiano, J. A., Berkovic, S. F., Shendure, J., Hildebrand, M. S., … Mefford, H. C. (2013). GRIN2A mutations cause epilepsy-aphasia spectrum disorders. Nature Genetics, 45(9), 1073-1076. https://doi.org/10.1038/ng.2727
Ciara, E., Rokicki, D., Lazniewski, M., Mierzewska, H., Jurkiewicz, E., Bekiesińska-Figatowska, M., Piekutowska-Abramczuk, D., Iwanicka-Pronicka, K., Szymańska, E., Stawiński, P., Kosińska, J., Pollak, A., Pronicki, M., Plewczyński, D., Płoski, R., & Pronicka, E. (2018). Clinical and molecular characteristics of newly reported mitochondrial disease entity caused by biallelic PARS2 mutations. Journal of Human Genetics, 63(4), 473-485. https://doi.org/10.1038/s10038-017-0401-z
Freibauer, A. E., RamachandranNair, R., Jain, P., Jones, K. C., & Whitney, R. (2023). The genetic landscape of developmental and epileptic encephalopathy with spike-and-wave activation in sleep. Seizure, 110, 119-125. https://doi.org/10.1016/j.seizure.2023.06.017
Jiang, E., Fitzgerald, M. P., Helbig, K. L., & Goldberg, E. M. (2022). IL1RAPL1 gene deletion in a female patient with developmental delay and continuous spike-wave during sleep. Journal of Pediatric Epilepsy, 11(1), 21-26. https://doi.org/10.1055/s-0041-1731816
Kessi, M., Peng, J., Yang, L., Xiong, J., Duan, H., Pang, N., & Yin, F. (2018). Genetic etiologies of the electrical status epilepticus during slow wave sleep: Systematic review. BMC Genetics, 19(1), 40. https://doi.org/10.1186/s12863-018-0628-5
Lesca, G., Møller, R. S., Rudolf, G., Hirsch, E., Hjalgrim, H., & Szepetowski, P. (2019). Update on the genetics of the epilepsy-aphasia spectrum and role of GRIN2A mutations. Epileptic Disorders, 21(S1), 41-47. https://doi.org/10.1684/epd.2019.1056
Maddirevula, S., Alzahrani, F., Al-Owain, M., Al Muhaizea, M. A., Kayyali, H. R., Al Hashem, A., Rahbeeni, Z., Al-Otaibi, M., Alzaidan, H. I., Balobaid, A., El Khashab, H. Y., Bubshait, D. K., Faden, M., Yamani, S. A., Dabbagh, O., Al-Mureikhi, M., Jasser, A. A., Alsaif, H. S., Alluhaydan, I., … Alkuraya, F. S. (2019). Autozygome and high throughput confirmation of disease genes candidacy. Genetics in Medicine, 21(3), 736-742. https://doi.org/10.1038/s41436-018-0138-x
Minardi, R., Licchetta, L., Baroni, M. C., Pippucci, T., Stipa, C., Mostacci, B., Severi, G., Toni, F., Bergonzini, L., Carelli, V., Seri, M., Tinuper, P., & Bisulli, F. (2020). Whole-exome sequencing in adult patients with developmental and epileptic encephalopathy: It is never too late. Clinical Genetics, 98(5), 477-485. https://doi.org/10.1111/cge.13823
Mir, A., Amer, F., Ali, M., Alotaibi, W., Alotaibi, M., Hedaithy, A., Aldurayhim, F., Hussain, F., Bashir, S., & Housawi, Y. (2023). Continuous spikes and waves during sleep (CSWS), severe epileptic encephalopathy, and choreoathetosis due to mutations in FRRS1L. Clinical EEG and Neuroscience, 54(5), 526-533. https://doi.org/10.1177/15500594221112508
Mizuguchi, T., Nakashima, M., Kato, M., Yamada, K., Okanishi, T., Ekhilevitch, N., Mandel, H., Eran, A., Toyono, M., Sawaishi, Y., Motoi, H., Shiina, M., Ogata, K., Miyatake, S., Miyake, N., Saitsu, H., & Matsumoto, N. (2017). PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder. Journal of Human Genetics, 62(5), 525-529. https://doi.org/10.1038/jhg.2016.163
Öztoprak, Ü., Yayici Köken, Ö., Aksoy, E., & Yüksel, D. (2021). Spike-wave index assessment and electro-clinical correlation in patients with encephalopathy associated with epileptic state during slow sleep (ESES/CSWS); single-center experience. Epilepsy Research, 170, 106549. https://doi.org/10.1016/j.eplepsyres.2021.106549
Pronicka, E., Piekutowska-Abramczuk, D., Ciara, E., Trubicka, J., Rokicki, D., Karkucińska-Więckowska, A., Pajdowska, M., Jurkiewicz, E., Halat, P., Kosińska, J., Pollak, A., Rydzanicz, M., Stawinski, P., Pronicki, M., Krajewska-Walasek, M., & Płoski, R. (2016). New perspective in diagnostics of mitochondrial disorders: Two years' experience with whole-exome sequencing at a national paediatric Centre. Journal of Translational Medicine, 14(1), 174. https://doi.org/10.1186/s12967-016-0930-9
Pronicka, E., Weglewska-Jurkiewicz, A., Pronicki, M., Sykut-Cegielska, J., Kowalski, P., Pajdowska, M., Jankowska, I., Kotulska, K., Kalicinski, P., Jakobkiewicz-Banecka, J., & Wegrzyn, G. (2011). Drug-resistant epilepsia and fulminant valproate liver toxicity. Alpers-Huttenlocher syndrome in two children confirmed postmortem by identification of p.W748S mutation in POLG gene. Medical Science Monitor, 17(4), CR203-CR209. https://doi.org/10.12659/msm.881716
Sofou, K., Kollberg, G., Holmström, M., Dávila, M., Darin, N., Gustafsson, C. M., Holme, E., Oldfors, A., Tulinius, M., & Asin-Cayuela, J. (2015). Whole exome sequencing reveals mutations in NARS2 and PARS2, encoding the mitochondrial asparaginyl-tRNA synthetase and prolyl-tRNA synthetase, in patients with Alpers syndrome. Molecular Genetics & Genomic Medicine, 3(1), 59-68. https://doi.org/10.1002/mgg3.115
Specchio, N., Wirrell, C., Scheffer, I., Nabbout, R., Riney, K., Samia, P., Guerreiro, M., Gwer, S., Zuberi, S. M., Wilmshurst, J. M., Yozawitz, E., Pressler, R., Hirsch, E., Wiebe, S., Cross, H. J., Perucca, E., Moshé, S. L., Tinuper, P., & Auvin, S. (2022). International league against epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE task force on nosology and definitions. Epilepsia, 63(6), 1398-1442. https://doi.org/10.1111/epi.17241
Tsai, M. H., Vears, D. F., Turner, S. J., Smith, R. L., Berkovic, S. F., Sadleir, L. G., & Scheffer, I. E. (2013). Clinical genetic study of the epilepsy-aphasia spectrum. Epilepsia, 54(2), 280-287. https://doi.org/10.1111/epi.12065
Veggiotti, P., Pera, M. C., Teutonico, F., Brazzo, D., Balottin, U., & Tassinari, C. A. (2012). Therapy of encephalopathy with status epilepticus during sleep (ESES/CSWS syndrome): An update. Epileptic Disorders, 14, 1-11. https://doi.org/10.1684/epd.2012.0482
Yin, X., Tang, B., Mao, X., Peng, J., Zeng, S., Wang, Y., Jiang, H., & Li, N. (2018). The genotypic and phenotypic spectrum of PARS2-related infantile-onset encephalopathy. Journal of Human Genetics, 63(9), 971-980. https://doi.org/10.1038/s10038-018-0478-z